Lantern Pharma and BenevolentAI News

This is selected news for Lantern Pharma and BenevolentAI, which are both filed under Sectors / Healthtech. There are 3 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
8/25/2022 AI Pharma Market Technological Advancements, Demand and Future Industry Trends 2028
... SAMPLE PDF @: Key companies profiled in this research study are: Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schr?dinger, Lantern Pharma, XtalPi, Landos Biopharma, Relay Therapeutics, Accutar Biotech, Deep Genomics, Oncocross, AI Therapeutics, BioMap, METiS Pharmaceuticals, NeoX Biotech, StoneWise, Deep Intelligent Pharma, Gigaceuticals, Chemical.AI ...
9/15/2020 2020 Global Drug Repurposing Service Providers Market - A Look at Repurposed Drugs in the Fight Against COVID-19
... in the drug repurposing domain. Companies Mentioned AbbVie Abiomics Europe Anaxomics Anticancer Fund Apodd Ariel University Astellas Pharma AstraZeneca Auxilis Pharma Avivia Bayer BayPoint Biosystems BenevolentAI Bill & Melinda Gates Biovista Bioxcel BioXplor Boehringer Ingelheim Bright Focus Foundation Cardiomedex ChemBio Discovery Solutions Chordoma Foundation Cloud Pharm Creative Biolabs ecancer Eli Lilly ...
PR Newswire
6/9/2020 Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry
... their clients: AcuraStem Inc., AI Therapeutics, Atomwise, BenevolentAI, BERG, Biovista Inc., Cotinga Pharmaceuticals Inc., Evaxion Biotech, Exscientia Ltd., Gritstone Oncology Inc., Healx Ltd, Insilico Medicine, Lantern Pharma Inc., Pharnext, Recursion Pharmaceuticals, and TwoXAR. Key takeaways: Better understand the growth environment from the perspective of industry experts. Gain insight into organizations ...
PR Newswire